152 related articles for article (PubMed ID: 14502496)
1. Partially unified multiple property recursive partitioning (PUMP-RP) analyses of cyclooxygenase (COX) inhibitors.
Rao SN; Stockfisch TP
J Chem Inf Comput Sci; 2003; 43(5):1614-22. PubMed ID: 14502496
[TBL] [Abstract][Full Text] [Related]
2. Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationships.
Sutherland JJ; O'Brien LA; Weaver DF
J Chem Inf Comput Sci; 2003; 43(6):1906-15. PubMed ID: 14632439
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
5. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
[TBL] [Abstract][Full Text] [Related]
6. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
[TBL] [Abstract][Full Text] [Related]
7. [Three dimensional quantitative structure-activity relationship of heterocyclic-compounds with di-tert-bultylphenyl inhibitors].
Bai AP; Guo ZR; Chu FM
Yao Xue Xue Bao; 2001 May; 36(5):347-50. PubMed ID: 12584856
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
[TBL] [Abstract][Full Text] [Related]
9. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
10. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
Rollinger JM; Haupt S; Stuppner H; Langer T
J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
[TBL] [Abstract][Full Text] [Related]
11. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
Hsu N; Cai D; Damodaran K; Gomez RF; Keck JG; Laborde E; Lum RT; Macke TJ; Martin G; Schow SR; Simon RJ; Villar HO; Wick MM; Beroza P
J Med Chem; 2004 Sep; 47(20):4875-80. PubMed ID: 15369391
[TBL] [Abstract][Full Text] [Related]
12. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1953-6. PubMed ID: 15050635
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of (E)-1,1,2-triarylethenes: novel inhibitors of the cyclooxygenase-2 (COX-2) isozyme.
Uddin MJ; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem Lett; 2005 Jan; 15(2):439-42. PubMed ID: 15603969
[TBL] [Abstract][Full Text] [Related]
14. Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.
Mozziconacci JC; Arnoult E; Bernard P; Do QT; Marot C; Morin-Allory L
J Med Chem; 2005 Feb; 48(4):1055-68. PubMed ID: 15715473
[TBL] [Abstract][Full Text] [Related]
15. Designing selective COX-2 inhibitors: molecular modeling approaches.
Trummlitz G; van Ryn J
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):550-61. PubMed ID: 12197313
[TBL] [Abstract][Full Text] [Related]
16. Exploring QSAR with E-state index: selectivity requirements for COX-2 versus COX-1 binding of terphenyl methyl sulfones and sulfonamides.
Chakraborty S; Sengupta C; Roy K
Bioorg Med Chem Lett; 2004 Sep; 14(18):4665-70. PubMed ID: 15324885
[TBL] [Abstract][Full Text] [Related]
17. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
Srinath P; Rao PN; Knaus EE; Suresh MR
Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
[TBL] [Abstract][Full Text] [Related]
19. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.
Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK
Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050
[TBL] [Abstract][Full Text] [Related]
20. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
